8-K: GrafTech International Receives Notice of Noncompliance from NYSE Due to Low Stock Price
8-K Filing
GrafTech International Ltd. received a notice from the NYSE stating it is not in compliance with continued listing standards because its average closing stock price was below $1.00 for 30 consecutive trading days.
Summary
- GrafTech International Ltd. received a notice from the New York Stock Exchange (NYSE) on April 15, 2025, indicating non-compliance with Section 802.01C of the NYSE's Listed Company Manual.
- The non-compliance is due to the company's average closing stock price being less than $1.00 per share over a consecutive 30 trading-day period ending on April 14, 2025.
- The notice does not immediately delist the company's common stock from the NYSE.
- GrafTech intends to notify the NYSE of its plan to cure the stock price deficiency and regain compliance.
- The company has a six-month cure period to regain compliance.
- To regain compliance, GrafTech's closing share price must be at least $1.00 on the last trading day of any calendar month during the cure period, and the average closing share price must be at least $1.00 over the 30 trading-day period ending on that last trading day.
- GrafTech is considering options to regain compliance, including a reverse stock split, subject to stockholder approval.
- The company's common stock will continue to trade on the NYSE under the symbol EAF with the designation '.BC' during the cure period.
- Failure to regain compliance could result in suspension and delisting of the company's common stock, potentially reducing liquidity and market price.
- The notice is not expected to impact the company's ongoing business operations or reporting requirements with the SEC.
Sentiment
Score: 3
Explanation: The sentiment is negative due to the notice of noncompliance from the NYSE, indicating financial distress and potential delisting. While the company is taking steps to address the issue, the situation presents significant risks.
Positives
- The notice does not result in immediate delisting.
- GrafTech has a six-month cure period to regain compliance.
- The company intends to remain listed on the NYSE and is considering options to regain compliance.
- The notice is not anticipated to impact the ongoing business operations of the company or its reporting requirements with the SEC.
Negatives
- GrafTech's stock price has fallen below the NYSE's continued listing standard.
- Failure to regain compliance could result in suspension and delisting from the NYSE.
- Delisting could negatively impact the company by reducing the liquidity and market price of its common stock.
Risks
- The notice and noncompliance with NYSE continued listing standards may impact the company's results of operations, business operations, and reputation.
- The notice and noncompliance with NYSE continued listing standards may impact the trading prices and volatility of the company's common stock.
- The company's ability to access the capital and credit markets could be adversely affected.
- The company may not be able to regain compliance with NYSE continued listing standards within the applicable cure period.
- The company may not be able to get stockholder approval to effectuate a reverse stock split or any other action requiring stockholder approval.
- The company may not be able to continue to meet NYSE continued listing standards.
Future Outlook
GrafTech intends to regain compliance with NYSE continued listing standards and is considering all available options, including a reverse stock split, subject to stockholder approval.
Management Comments
- The Company plans to timely notify the NYSE that it intends to cure the stock price deficiency and return to compliance with the applicable NYSE continued listing standards.
- The Company intends to remain listed on the NYSE and is considering all available options to regain compliance with the NYSEs continued listing standards, including, but not limited to, a reverse stock split, subject to stockholder approval.
Industry Context
This announcement reflects the challenges faced by companies in maintaining stock prices that meet exchange listing requirements, particularly in volatile market conditions or during periods of financial difficulty.
Comparison to Industry Standards
- Many companies in the materials and manufacturing sectors have faced similar challenges with maintaining stock prices above the minimum listing requirements.
- Comparable companies that have undergone reverse stock splits to maintain listing compliance include [hypothetical company A] and [hypothetical company B].
- The success of a reverse stock split in restoring compliance depends on various factors, including investor sentiment and the company's underlying financial performance.
Stakeholder Impact
- Shareholders may experience increased volatility and potential dilution if a reverse stock split is implemented.
- Employees may be concerned about the company's financial stability and future prospects.
- Customers and suppliers may monitor the situation to assess the company's long-term viability.
Next Steps
- GrafTech plans to notify the NYSE of its intent to cure the stock price deficiency.
- The company will consider options to regain compliance, including a reverse stock split, subject to stockholder approval.
- GrafTech must achieve a closing share price of at least $1.00 and an average closing share price of at least $1.00 over a 30 trading-day period within the six-month cure period.
Key Dates
| Date | Description |
|---|---|
| April 14, 2025 | End of the 30 trading-day period where the average closing stock price was less than $1.00. |
| April 15, 2025 | Date GrafTech received the noncompliance notice from the NYSE. |
| April 18, 2025 | Date of the press release announcing the receipt of the noncompliance notice. |
Keywords
NYSE, delisting, compliance, stock price, GrafTech, listing standards, reverse stock split
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.